Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2004-06-18
2010-02-09
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S009100, C424S001110
Reexamination Certificate
active
07658912
ABSTRACT:
A method for identifying a candidate drug includes administering a test compound to test subjects and having the test subjects perform a sustained task. A first evolution of neural activity in the test subjects is then determined and compared with a second evolution of neural activity. This second evolution of neural activity is obtained from control subjects performing the sustained task in the absence of the test compound. The test compound is then designated to be a candidate drug when a difference between the first and second evolutions of neural activity is above a difference threshold.
REFERENCES:
patent: 7166438 (2007-01-01), Patchev et al.
patent: 2005/0019261 (2005-01-01), Albrecht et al.
Panisset et al (2002), Journal of Neural Transmission, vol. 109, Nos. 7-8, pp. 1089-1104.
Paskavitz JF, Sweet LH, Wellen J, Helmer KG, Cohen RA. “Dynamic Changes in Brain Volumes of Activation During Sustained Working Memory Observed with fMRI,” International Neuropsychological Society Annual Meeting, 2003, Honolulu, Hawaii, JINS, 2003, 9(2); 321.
Braver, et al. “A Parametric Study of Prefrontal Cortex Involvement in Human Working Memory,” Neuroimage 1997, 5:49-62.
Cox, “AFNI Software for Analysis and Visualization of Functional Magnetic Resonance Neuroimages,” Compt. Biomed. Res., 1996, 29:129-173.
Rao, et al. “Functional magnetic resonance imaging of complex human movements,” Neurology 43:2311-2318 (1993).
Wellen, J., “Characterization of Soft-Tissue Response to Mechanical Loading Using Nuclear Magnetic Resonance (NMR) and Functional Magnetic Resonance (fMRI) of Neuronal Activity During Sustained Cognitive-Stimulus Paradigms,” PhD thesis, Worcester Polytechnic Institute, Defended May 2003, Published Jun. 2003, Chapter 6, “Functional Brain Imaging,” 7 pages and Chapter 7 “Dynamic Changes in Neural Network Activation Patterns,” 21 pages.
“Brain Mapping: the methods” 2d ed. Chapter 22, “Statistics I: Experimental Design and Statistical Parametric Mapping,” contributed by Karl J. Friston, (2002), pp. 605-631.
M. Samuel, et al., “Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI,” 1998, Neurology 1998; 51: 1567-1575.
J. W. Fisher, III, et al. “Adaptive Entropy Rates for fMRI Time-Series Analysis,” MICCAI 2001, 4thInt'l Conf., Utrecht, Netherlands, Oct. 14-17, 2001.
Paskavitz James F.
Sweet Larry H.
Fish & Richardson P.C.
Jones D L
University of Massachusetts
LandOfFree
Spatial evolution of neural activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spatial evolution of neural activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spatial evolution of neural activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4204216